Tiapride pre-treatment in acute exposure to paraoxon: Comparison of effects of administration at different points-in-time in rats

Molecular and Cellular Biochemistry

Volumn 285, Issue 1-2, 2006, Pages 79-86

  Petroianu, Georg A ^a   Hasan, M Y ^a   Nurulain, S M ^a   Arafat, K ^a   Shafiullah, M ^a   Sheen, R ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cholinesterase; Organophosphate; Paraoxon; Tiapride; Treatment

Indexed keywords

ACETYLCHOLINESTERASE; PARAOXON; PYRIDOSTIGMINE; TIAPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; ENZYME ACTIVITY; EXPOSURE; FEMALE; KAPLAN MEIER METHOD; MALE; MORTALITY; NONHUMAN; PROSPECTIVE STUDY; RANK SUM TEST; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TOXICOKINETICS;

ANIMALS; CHOLINESTERASES; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTES; FEMALE; MALE; PARAOXON; PROSPECTIVE STUDIES; RATS; RATS, WISTAR; SURVIVAL ANALYSIS; TIAPRIDE; TIME FACTORS;

ANIMALIA;

EID: 33646154667     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9057-7     Document Type: Article

References (32)

1. Levine R: Recognized and possible effects of pesticides in humans. In WJ Hayes, ER Laws (ed.), Handbook of Pesticide Toxicology, General Principles, Academic Press. San Diego, vol. 1, pp. 275-360, 1991
2. Bajgar J: Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis and treatment. Advances Clin Chem 38: 151-216, 2004
3. Jeyaratnam J: Acute pAsticide poisoning: a major global health problem. World Health Stat Q 43: 139-144, 1990
4. Karalliedde L: Organophosphourus poisoning and anaesthesia. Anaesthesia 54: 1073-1088, 1999
5. Namba T: Cholinesterase inhibition by organophospourus compounds, and its clinical effects. Bull WHO 44: 289-307, 1971
6. Namba T, Nolte CT, Jackrel J, Grob D: Poisoning due to organophosphate insecticides: Acute and chronic manifestations. Am J Med 50: 457-492, 1971
7. Zoch E: Die Wirkung organischer Phosphorsäureester bzw. Phosphorsäureester auf versch. Enzyme Arzneim Forschung 21: 181-187, 1971
8. Petroianu G, Toomes LM, Petroianu A, Bergler W, Rufer R: Control of blood pressure, heart rate and haematocrit during high-dose intravenous Paraoxon exposure in mini pigs. J Appl Toxicol 18: 293-298, 1998
9. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC et al.: Evaluation of antidotes for poisoning by organophosphourus pesticides. Emerg Med 12: 22-37, 2000
10. van Helden HP, Busker RW, Melchers BP, Bruijnzeel PL: Pharmacological effects of oximes: How relevant are they? Arch Toxicol 70: 779-786, 1996
11. Peter JV, Cherian AM: Organic insecticides. Anaesth Intensive Care 28: 11-21, 2000
12. Worek F, Szinicz L, Eyer P, Thiermann H. Evaluation of oxime efficacy in nerve agent poisoning: Development of a kinetic-based dynamic model. Toxicol Appl Pharmacol. 2005 May 16 [Epub ahead of print]
13. Petroianu GA, Arafat K, Kuca K, Kassa J: Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: In vitro reactivation of red blood cell acetylcholinesterase inhibitied by paraoxon. J Appl Toxicol 2005 Sep 29 [Epub ahead of print]
14. Gordon JJ, Leadbeater L, Maidment MP: The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol 43: 207-216, 1978
15. Wiener SA, Hoffman RS: Nerve agents: a comprehensive review. J Intensive Care Med 19: 22-37, 2004
16. Marino MT, Schuster BG, Brueckner RP, Lin E, Kaminskis A, Lasseter KC: Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J Clin Pharmacol 38: 227-235, 1998
17. Fontaine J, Reuse J: The effects of substituted benzamides on frog rectus abdominis. Eur J Pharmacol 68: 55-60, 1980
18. Petroianu GA, Arafat K, Schmitt A, Hasan MY: Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): In vitro effect of ranitidine. J Appl Toxicol 25: 60-67, 2005
19. Petroianu GA, Hasan MY, Nurulain SM, Arafat K, Shafiullah M, Naseer OP: Protective agents in acute high dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats. J Appl Toxicol 25: 68-73, 2005
20. Petroianu GA, Arafat K, Schmitt A, Hasan MY: Weak inhibitors protect cholinesterases from strong inhibitors (dichlorvos): In vitro effect of tiapride. Internat J Toxicol 24: 79-86, 2005
21. Petroianu GA, Hasan MY, Nurulain SM, Arafat K, Sheen R, Saleh A, Schmitt A: Protective agents in acute high dose exposure to organophosphates: comparison of metoclopramide and tiapride with pralidoxime in rats. Anesth Analg 100: 382-386, 2005
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Amer Statist Assoc 53: 457-81, 1958
23. Dawson JD, Lagakos SW: Size and power of two sampled tests of repeated measures data. Biometrics 49: 1022-1032, 1993
24. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P: Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288: 73-90, 1999
25. Ellman GL, Courtney KD, Feather-Stone RM, Andres V Jr: A new and rapid colorimetric determination of acetyl-cholinesterase activity. Biochem Pharmacol 7: 88-95, 1961
26. van Kampen EJ, Zijlstra WG: Standardization of hemoglobinometry II. The hemoglobincyanide method. Clin Chim Acta 6: 538-544, 1961
27. Dart RC, Goldfrank LR, Chyka PA, Lotzer D, Woolf AD, McNally J, Snodgrass WR, Olson KR, Scharman E, Geller RJ, Spyker D, Kraft M, Lipsy R: Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med 36: 126-132, 2000
28. Petroianu G, Arafat K, Kosanovic M, Saleh A, Camasamudram V, Hassan MY: In vitro protection of RBC acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox). J Appl Toxicol 23: 447-451, 2003
29. Hasan MY, Nurulain SM, Arafat K, Naseer OP, Petroianu GA: In-vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in sub-chronic low dose exposure. J Appl Toxicol 24: 257-260, 2004
30. Delmeire F: Tiapridal. Acta Psychiatr Belg 80: 191-201, 1980
31. Satoh H, Nakanishi H, Shirakawa K, Kohjimoto Y, Kuwaki T, Ono T, Shibayama F: Comparative study of tiapride and neuroleptics with anti-dopamine activity on convulsive seizure in mice. Jpn J Pharmacol 43: 27-32, 1987
32. Warter JM, Vergnes M, Depaulis A, Tranchant C, Rumbach L, Micheletti G, Marescaux C: Effects of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures. Neuropharmacology 27: 269-274, 1988